Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial (Q40701951)
Jump to navigation
Jump to search
scientific article published on 20 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial |
scientific article published on 20 July 2015 |
Statements
1 reference
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial (English)
1 reference
Michael A Henderson
Bryan H Burmeister
Jill Ainslie
Richard Fisher
Juliana Di Iulio
Kerwin Shannon
Scott Carruthers
Brendon J Coventry
Scott Babington
Joao Duprat
Harald J Hoekstra
20 July 2015
1 reference